These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33999634)

  • 21. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymol/cyclodextrin inclusion complex nanofibrous webs: Enhanced water solubility, high thermal stability and antioxidant property of thymol.
    Celebioglu A; Yildiz ZI; Uyar T
    Food Res Int; 2018 Apr; 106():280-290. PubMed ID: 29579928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cyclodextrin derivation and amorphous state of complex on accelerated degradation of ziprasidone.
    Hong J; Shah JC; Mcgonagle MD
    J Pharm Sci; 2011 Jul; 100(7):2703-16. PubMed ID: 21283987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of cyclodextrins as solubilizing agents for simvastatin: effect of hydroxypropyl-β-cyclodextrin on lactone/hydroxyacid aqueous equilibrium.
    Ungaro F; Giovino C; Catanzano O; Miro A; Mele A; Quaglia F; La Rotonda MI
    Int J Pharm; 2011 Feb; 404(1-2):49-56. PubMed ID: 21056648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of ibuproxam complexation with amorphous beta-cyclodextrin derivatives in solution and in the solid state.
    Mura P; Zerrouk N; Faucci M; Maestrelli F; Chemtob C
    Eur J Pharm Biopharm; 2002 Sep; 54(2):181-91. PubMed ID: 12191690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solubilization of Fluasterone in cosolvent/cyclodextrin combinations.
    He Y; Li P; Yalkowsky SH
    Int J Pharm; 2003 Oct; 264(1-2):25-34. PubMed ID: 12972333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of hydroxypropyl-Beta-cyclodextrin on the stability of dilute and highly concentrated immunoglobulin g formulations.
    Härtl E; Winter G; Besheer A
    J Pharm Sci; 2013 Nov; 102(11):4121-31. PubMed ID: 24105716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risperidone/Randomly Methylated β-Cyclodextrin Inclusion Complex-Compatibility Study with Pharmaceutical Excipients.
    Sbârcea L; Tănase IM; Ledeți A; Cîrcioban D; Vlase G; Barvinschi P; Miclău M; Văruţ RM; Suciu O; Ledeți I
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33802960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxypropyl-β-Cyclodextrin and β-Cyclodextrin as Tablet Fillers for Direct Compression.
    Conceição J; Adeoye O; Cabral-Marques HM; Sousa Lobo JM
    AAPS PharmSciTech; 2018 Aug; 19(6):2710-2718. PubMed ID: 29978292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes.
    Sathigari S; Chadha G; Lee YH; Wright N; Parsons DL; Rangari VK; Fasina O; Babu RJ
    AAPS PharmSciTech; 2009; 10(1):81-7. PubMed ID: 19148759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physicochemical properties of inclusion complexes of highly soluble β-cyclodextrins with highly hydrophobic testosterone propionate.
    Celia C; Scala A; Stancanelli R; Surdo E; Paolino D; Grattoni A; Micale N; Crupi V; Majolino D; Fresta M; Tommasini S; Venuti V; Ventura CA
    Int J Pharm; 2017 Dec; 534(1-2):316-324. PubMed ID: 29042336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative chemical examination of inclusion complexes formed with β-cyclodextrin derivatives and basic amino acids.
    Esmaeilpour D; Shityakov S; Tamaddon AM; Bordbar AK
    Carbohydr Polym; 2021 Jun; 262():117868. PubMed ID: 33838791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.
    Chi L; Liu R; Guo T; Wang M; Liao Z; Wu L; Li H; Wu D; Zhang J
    Int J Pharm; 2015 Feb; 479(2):349-56. PubMed ID: 25575474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions.
    Brewster ME; Vandecruys R; Peeters J; Neeskens P; Verreck G; Loftsson T
    Eur J Pharm Sci; 2008 Jul; 34(2-3):94-103. PubMed ID: 18420390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-inclusion complexes between riboflavin and cyclodextrins.
    de Jesus MB; Fraceto LF; Martini MF; Pickholz M; Ferreira CV; de Paula E
    J Pharm Pharmacol; 2012 Jun; 64(6):832-42. PubMed ID: 22571261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carvedilol: solubilization and cyclodextrin complexation: a technical note.
    Loftsson T; Vogensen SB; Desbos C; Jansook P
    AAPS PharmSciTech; 2008; 9(2):425-30. PubMed ID: 18431667
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of Surfactants on Surface-Induced Denaturation of Proteins: Evidence of an Orientation-Dependent Mechanism.
    Arsiccio A; McCarty J; Pisano R; Shea JE
    J Phys Chem B; 2018 Dec; 122(49):11390-11399. PubMed ID: 30118226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydrosoluble cyclodextrin/poloxamer polypseudorotaxanes at the air/water interface, in bulk solution, and in the gel state.
    Nogueiras-Nieto L; Alvarez-Lorenzo C; Sandez-Macho I; Concheiro A; Otero-Espinar FJ
    J Phys Chem B; 2009 Mar; 113(9):2773-82. PubMed ID: 19708112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracorneal melatonin delivery using 2-hydroxypropyl-β-cyclodextrin ophthalmic solution for granular corneal dystrophy type 2.
    Ahn JH; Kim HD; Abuzar SM; Lee JY; Jin SE; Kim EK; Hwang SJ
    Int J Pharm; 2017 Aug; 529(1-2):608-616. PubMed ID: 28694094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellulose-based matrix microspheres of prednisolone inclusion complex: preparation and characterization.
    Palanisamy M; Khanam J
    AAPS PharmSciTech; 2011 Mar; 12(1):388-400. PubMed ID: 21359603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.